India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

India's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...

Glenmark Pharmaceuticals has launched a groundbreaking nebulised triple therapy for COPD. This single, easy-to-use treatment combines three...

Glenmark Pharmaceuticals Ltd announced that its subsidiary, Glenmark Specialty S A (GSSA), has entered into a license agreement with Jiangs...

"The over-the-counter market has long been an important segment of Glenmark's portfolio around the world. Our acquisition of these ANDAs re...

Glenmark will receive an upfront payment as well as regulatory and sales-based milestone payments from Lotus, it added.

The Mumbai based drug firm said it has introduced fixed dose combination (FDC) of its novel, patent protected Sodium Glucose Co-Transporter...

Drug firm Glenmark Pharma on Tuesday announced the launch of Tiotropium Bromide Dry Powder Inhaler, used in the treatment of chronic obstru...

Glenmark being one of the leaders in respiratory segment, has been the first to launch the branded generic version at an affordable cost fo...

“Compared to other therapies approved for emergency use in COVID-19, FabiFlu is much more economical and an effective treatment option,” th...

Drug Controller General (India) VG Somani in a letter dated July 17 has asked for a clarification on the matter for taking necessary action.

Glenmark said it will commercialise Remogliflozin in India under the brand names 'Remo' and 'Remozen'.

The approval is valid for six months, during which the company will apply to the High Court for further clearance of the proposal.

Glenmark Pharmaceuticals' board today approved a merger of two subsidiaries -- Glenmark Generics and Glenmark Access -- with itself.

As part of the agreement, Glenmark will receive up to $ 9 million (around Rs 50 crore) from US-based Forest Laboratories Inc.

Glenmark Pharmaceuticals on Wednesday said its European arm, Medicamenta, has acquired seven pharmaceutical brands from Iceland-based gener...

Drug maker Glenmark Pharmaceuticals today said it has signed agreements with Iceland-based Actavis to acquire seven pharmaceutical brands i...